Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms. [PDF]
J Thromb Haemost, 2020 Keshava S +3 more
europepmc +1 more source
Recombinant Factor VIIa : A Universal Haemostatic Agent?
Annals of Cardiac Anaesthesia, 2006 Gill R, Herbertson M
doaj
Use of Factor VIIa and Anti-inhibitor Coagulant Complex in Pediatric Cardiac Surgery Patients. [PDF]
J Pediatr Pharmacol Ther, 2020 Carroll RB +4 more
europepmc +1 more source
MicroRNA-10a enrichment in factor VIIa-released endothelial extracellular vesicles: potential mechanisms. [PDF]
J Thromb HaemostDas K +4 more
europepmc +1 more source
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors. [PDF]
Haemophilia, 2019 Meeks SL, Leissinger CA.
europepmc +1 more source
FVIIa (Factor VIIa) Induces Biased Cytoprotective Signaling in Mice Through the Cleavage of PAR (Protease-Activated Receptor)-1 at Canonical Arg41 (Arginine41) Site. [PDF]
Arterioscler Thromb Vasc Biol, 2020 Kondreddy V +4 more
europepmc +1 more source
Large herbivores in the wildwood and modern naturalistic grazing systems [PDF]
, 2005 Buckland, Paul C. +3 more
core
Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa. [PDF]
J Biol Chem, 2020 Sorensen AB +7 more
europepmc +1 more source
Targeting platelet EPCR for better therapeutic factor VIIa activity. [PDF]
J Thromb Haemost, 2018 Gu SX, Lentz SR.
europepmc +1 more source
Thrombosis and recombinant factor VIIa [PDF]
Journal of Thrombosis and Haemostasis, 2004 openaire +2 more sources